algorithmRx Awarded Grant From Virginia Center For Innovative Technology
Monday, June 30, 2014
algorithmRx, LLC was one of only four private companies in the Greater Richmond, Virginia area that received a $50,000 grant from the Virginia Center for Innovative Technology (CIT) for its innovative new aRx Statin Advisor product. algorithmRx received this grant for the second time.
The grant was one of 38 awards made to Virginia organizations in academia, the research community and industry to fund targeted areas of research with commercial promise aligned with the Commonwealth Research and Technology Strategic Roadmap.
aRx Statin Advisor is the first in a suite of novel, patent-pending, healthcare algorithms from algorithmRx designed to improve the medication management of common chronic health conditions. aRx Statin Advisor is an evidence-based clinical decision-support system (CDSS) designed to assist clinicians in selecting the most effective statin and dose regimen for patients with high LDL-cholesterol (“LDL-C” or “bad cholesterol”).
“By identifying the right statin in the right dose the first time, aRx Statin Advisor may reduce the cost, time and patient/provider frustration often associated with reaching and maintaining target LDL-C levels”, relates Barbara Zedler, MD and Chief Medical Officer of algorithmRx.